MELISSA BATES: Open Payments
NPI 1962571331 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 24 payments from 6 companies in 2025. Trend: 2023 $855 · 2024 $2,210 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 12 | $518 |
| ABBVIE INC. | 7 | $153 |
| Astellas Pharma US Inc | 2 | $67 |
| Lilly USA, LLC | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $15 |
Products named: INTERSTIM, Veozah, QULIPTA, LO LOESTRIN FE, UBRELVY, MOUNJARO, EVENITY, BOTOX.
Industry payments across ID — which companies pay providers there.
